Cargando…
Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis
BACKGROUND: Children hospitalised with severe anaemia in malaria-endemic areas are at a high risk of dying or being readmitted within six months of discharge. A trial in Kenya and Uganda showed that three months of postdischarge malaria chemoprevention (PDMC) with monthly dihydroartemisinin-piperaqu...
Autores principales: | Kühl, Melf-Jakob, Gondwe, Thandile, Dhabangi, Aggrey, Kwambai, Titus K., Mori, Amani T., Opoka, Robert, John, C. Chandy, Idro, Richard, ter Kuile, Feiko O., Phiri, Kamija S., Robberstad, Bjarne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596312/ https://www.ncbi.nlm.nih.gov/pubmed/36313146 http://dx.doi.org/10.1016/j.eclinm.2022.101669 |
Ejemplares similares
-
Predicting adherence to postdischarge malaria chemoprevention in Malawian pre-school children: A prognostic multivariable analysis
por: Kühl, Melf-Jakob, et al.
Publicado: (2023) -
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa
por: Okell, Lucy C., et al.
Publicado: (2023) -
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial
por: Nkosi-Gondwe, Thandile, et al.
Publicado: (2021) -
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial
por: Kwambai, Titus K., et al.
Publicado: (2018) -
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial
por: Nkosi-Gondwe, Thandile, et al.
Publicado: (2023)